WASHINGTON - The head of a House subcommittee that oversees the FDA has demanded answers from Commissioner Margaret Hamburg about why the agency is considering "outsourcing" the efficacy analyses of older marketed antibiotics to a nonprofit standards-setting group, whose 2,000 members include numerous drugmakers. (BioWorld Today)